Immunogenicity and Safety Study of Booster Vaccine With the COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain
Phase 2
Completed
- Conditions
- COVID-19
- Interventions
- Biological: COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain
- First Posted Date
- 2022-06-09
- Last Posted Date
- 2023-09-22
- Lead Sponsor
- Sinovac Biotech (Hong Kong) Limited
- Target Recruit Count
- 221
- Registration Number
- NCT05411471
- Locations
- 🇨🇳
Gleneagles Hospital HongKong, Hong Kong, China
© Copyright 2025. All Rights Reserved by MedPath